| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 235.5 | 192.6 | 193.0 |
| Other income | 7.2 | 31.5 | 4.0 |
| Total income | 242.8 | 224.1 | 196.9 |
| Profit before exceptional items & tax | 22.4 | 51.7 | 27.4 |
| Profit before tax | 22.4 | 51.7 | 27.4 |
| Net profit | 16.6 | 41.7 | 20.5 |
| Operating margin | 9.2% | 23.1% | 13.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -19.00% |
|---|---|
| Net profit, quarter on quarter | -60.20% |
| Revenue, year on year | +22.00% |
| Operating profit, year on year | -35.00% |
| Operating profit, quarter on quarter | -24.80% |
BSE results filing, NSE: KRSNAA. Figures extracted from the filing.
Krsnaa Diagnostics Ltd: key numbers
- Share price
- ₹548.45
- Market cap
- ₹1,779 Cr
- Revenue (annual)
- ₹772.8 Cr
- Net profit (annual)
- ₹101.4 Cr
- P/E (TTM)
- 18.2×Sector 57.8×
- Promoter holding
- 27.11%+0.00% QoQ
- FII holding
- 4.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krsnaa Diagnostics Ltd
All →Krsnaa Diagnostics Annual General Meeting
Krsnaa Diagnostics Ltd reported the successful passing of a special resolution via postal ballot approving the issuance of up to 16,21,000 convertible warrants to promoters.
Krsnaa Diagnostics Bags New Order from Department of Health & Family Welfare, Government of Punjab
Krsnaa Diagnostics executed a 15-year concession agreement with the Punjab Government to develop and operate PET-CT diagnostic facilities at four government hospitals.
- From
- Department of Health & Family Welfare, Government of Punjab
- Execution
- 15 years
- diagnostic facilities
- 4.0 hospitals
Krsnaa Diagnostics Legal & Regulatory
Krsnaa Diagnostics received tax appellate orders for AY 2017-24 with aggregate disputed demands of ₹62.69 Crore. The company plans to file further appeals.
- Value
- ₹62.69 Cr
Krsnaa Diagnostics Other Announcement
Krsnaa Diagnostics has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 as required by regulatory listing obligations.
Krsnaa Diagnostics Annual General Meeting
Krsnaa Diagnostics Limited has submitted the notice of its 16th Annual General Meeting, scheduled for September 28, 2026, along with the Annual Report for 2025-26.
Krsnaa Diagnostics Earnings Call Transcript: Key Takeaways
Krsnaa reported 22% revenue growth but suffered margin compression due to heavy front-ended costs for the Rajasthan project. Management pivots to 'long-term value' to deflect from current EBITDA and PAT dips.
- Call
- Guides 100% growth